Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 56,664 | 49,848 | 89,913 | 137,648 | 281,384 |
| General And Administrative Expense | 56,664 | 49,848 | 89,913 | 137,648 | 281,384 |
| Other Operating Expenses | 37,071 | 36,379 | -42,106 | 111,316 | 55,466 |
| Operating Expense | 93,735 | 86,227 | 47,807 | 248,964 | 336,850 |
| Operating Income | -93,735 | -86,227 | -47,807 | -248,964 | -336,850 |
| EBIT | -93,735 | -86,227 | -47,807 | -248,964 | -336,850 |
| Interest Income | -- | -- | 6,425 | 16,262 | 15,740 |
| Interest Income Non Operating | -- | -- | 6,425 | 16,262 | 15,740 |
| Net Interest Income | -- | -- | 6,425 | 16,262 | 15,740 |
| Other Income Expense | -8,762 | 198,235 | 353,696 | 383,560 | 32,945 |
| Other Non Operating Income Expenses | 2,042 | 3,272 | 96,680 | 64,189 | 34,183 |
| Special Income Charges | 0.00 | 204,963 | -- | -- | 0.00 |
| Gain On Sale Of Security | -10,804 | -10,000 | 350,000 | 319,371 | -1,238 |
| Pretax Income | -102,497 | 112,008 | 312,314 | 150,858 | -303,905 |
| Tax Effect Of Unusual Items | 0.00 | 29,244 | 38,552 | 47,906 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -102,497 | 112,008 | 312,314 | 150,858 | -303,905 |
| Net Income From Continuing Operation Net Minority Interest | -102,497 | 112,008 | 312,314 | 150,858 | -303,905 |
| Net Income Including Noncontrolling Interests | -102,497 | 112,008 | 312,314 | 150,858 | -303,905 |
| Net Income Common Stockholders | -102,497 | 112,008 | 312,314 | 150,858 | -303,905 |
| Net Income | -102,497 | 112,008 | 312,314 | 150,858 | -303,905 |
| EBITDA | -93,735 | -86,227 | -47,807 | -248,964 | -336,850 |
| Normalized EBITDA | -82,931 | -281,190 | -304,823 | -568,335 | -335,612 |
| Basic EPS | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Diluted EPS | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Basic Average Shares | 86.5M | 75.7M | -- | 89.7M | 85.0M |
| Diluted Average Shares | 86.5M | 75.7M | -- | 89.7M | 85.0M |
| Total Unusual Items | -10,804 | 194,963 | 257,016 | 319,371 | -1,238 |
| Total Unusual Items Excluding Goodwill | -10,804 | 194,963 | 257,016 | 319,371 | -1,238 |
| Tax Rate For Calcs | 0.00 | 0.15 | 0.15 | 0.15 | 0.00 |
| Normalized Income | -91,693 | -53,711 | 93,850 | -120,607 | -302,667 |
| Diluted NI Availto Com Stockholders | -102,497 | 112,008 | 312,314 | 150,858 | -303,905 |
| Gain On Sale Of Business | -- | -- | -- | -- | 0.00 |
| Gain On Sale Of Ppe | 0.00 | 241,213 | -- | -- | 0.00 |
| Impairment Of Capital Assets | 0.00 | 36,250 | -- | -- | 0.00 |
| Insurance And Claims | 2,975 | 2,975 | 5,567 | 7,487 | 7,488 |
| Net Income Continuous Operations | -102,497 | 112,008 | 312,314 | 150,858 | -303,905 |
| Net Non Operating Interest Income Expense | -- | -- | 6,425 | 16,262 | 15,740 |
| Other Gand A | 31,189 | 18,540 | 63,346 | 109,161 | 153,773 |
| Rent And Landing Fees | 22,500 | 22,500 | 21,000 | 21,000 | 21,000 |
| Rent Expense Supplemental | 22,500 | 22,500 | 21,000 | 21,000 | 21,000 |
| Salaries And Wages | 0.00 | 5,833 | 0.00 | 0.00 | 99,123 |
| Total Expenses | 93,735 | 86,227 | 47,807 | 248,964 | 336,850 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 336,531 | 409,191 | 530,345 | 1.1M | 1.8M |
| Cash Cash Equivalents And Short Term Investments | 336,531 | 409,191 | 530,345 | 1.1M | 1.8M |
| Cash Equivalents | 0.00 | 0.00 | 0.00 | 802,110 | 813,108 |
| Cash Financial | 336,531 | 409,191 | 530,345 | 316,266 | 952,570 |
| Accounts Receivable | 47,512 | 152,044 | 145,920 | 39,795 | 30,553 |
| Receivables | 47,512 | 152,044 | 145,920 | 39,795 | 30,553 |
| Prepaid Assets | 50,525 | 58,774 | 78,223 | 297,165 | 208,406 |
| Current Assets | 434,568 | 620,009 | 754,488 | 1.5M | 2.0M |
| Net PPE | 7.4M | 7.3M | 7.4M | 6.8M | 6.5M |
| Investments And Advances | 1.1M | 1.2M | 770,000 | 420,000 | 100,000 |
| Total Non Current Assets | 8.6M | 8.5M | 8.2M | 7.2M | 6.6M |
| Total Assets | 9.0M | 9.1M | 8.9M | 8.7M | 8.6M |
| Accounts Payable | -- | 133,536 | -- | -- | -- |
| Payables | -- | 142,992 | -- | -- | -- |
| Payables And Accrued Expenses | 122,804 | 142,992 | 139,631 | 106,720 | 104,335 |
| Other Current Liabilities | -- | -- | -- | 96,680 | 160,869 |
| Current Liabilities | 222,804 | 242,992 | 239,631 | 303,400 | 365,204 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 222,804 | 242,992 | 239,631 | 303,400 | 365,204 |
| Common Stock | 15.5M | 15.5M | 15.4M | 15.4M | 15.4M |
| Capital Stock | 15.5M | 15.5M | 15.4M | 15.4M | 15.4M |
| Retained Earnings | -7.6M | -7.6M | -7.7M | -8.0M | -8.2M |
| Gains Losses Not Affecting Retained Earnings | 883,659 | 998,782 | 1.0M | 1.0M | 1.0M |
| Common Stock Equity | 8.8M | 8.8M | 8.7M | 8.4M | 8.2M |
| Stockholders Equity | 8.8M | 8.8M | 8.7M | 8.4M | 8.2M |
| Total Equity Gross Minority Interest | 8.8M | 8.8M | 8.7M | 8.4M | 8.2M |
| Total Capitalization | 8.8M | 8.8M | 8.7M | 8.4M | 8.2M |
| Net Tangible Assets | 8.8M | 8.8M | 8.7M | 8.4M | 8.2M |
| Tangible Book Value | 8.8M | 8.8M | 8.7M | 8.4M | 8.2M |
| Working Capital | 211,764 | 377,017 | 514,857 | 1.2M | 1.6M |
| Invested Capital | 8.8M | 8.8M | 8.7M | 8.4M | 8.2M |
| Share Issued | 91.6M | 90.6M | 89.7M | 89.7M | 89.7M |
| Ordinary Shares Number | 91.6M | 90.6M | 89.7M | 89.7M | 89.7M |
| Available For Sale Securities | 1.1M | 1.2M | 770,000 | 420,000 | 100,000 |
| Current Provisions | 100,000 | 100,000 | 100,000 | 100,000 | 100,000 |
| Dueto Related Parties Current | -- | 9,456 | -- | -- | -- |
| Investmentin Financial Assets | 1.1M | 1.2M | 770,000 | 420,000 | 100,000 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | 96.00 | -60,436 | 23,150 | -247,754 | -257,487 |
| Cash Flow From Continuing Operating Activities | 96.00 | -60,436 | 23,150 | -247,754 | -257,487 |
| Stock Based Compensation | 0.00 | 5,833 | 0.00 | 0.00 | 99,123 |
| Change In Working Capital | 92,593 | 16,686 | 145,725 | -95,615 | -34,262 |
| Changes In Account Receivables | 104,532 | -6,124 | -106,128 | -9,242 | 113,019 |
| Change In Receivables | 104,532 | -6,124 | -106,128 | -9,242 | 113,019 |
| Change In Payables And Accrued Expense | -20,188 | 3,361 | 32,910 | 2,386 | 6,677 |
| Change In Other Working Capital | -- | -- | -- | -- | -- |
| Other Non Cash Items | -- | -- | -177,873 | 17,003 | -18,443 |
| Capital Expenditure | -72,756 | -60,718 | -621,413 | -399,548 | -12,454 |
| Purchase Of PPE | -72,756 | -60,718 | -621,413 | -399,548 | -12,454 |
| Net PPE Purchase And Sale | -72,756 | -60,718 | -621,413 | -399,548 | -12,454 |
| Investing Cash Flow | -72,756 | -60,718 | -621,413 | -399,548 | -12,454 |
| Cash Flow From Continuing Investing Activities | -72,756 | -60,718 | -621,413 | -399,548 | -12,454 |
| Issuance Of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 | 1.0M |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 1.0M |
| Financing Cash Flow | 0.00 | 0.00 | 10,232 | 0.00 | 972,249 |
| Cash Flow From Continuing Financing Activities | 0.00 | 0.00 | 10,232 | 0.00 | 972,249 |
| Changes In Cash | -72,660 | -121,154 | -588,031 | -647,302 | 702,308 |
| Beginning Cash Position | 409,191 | 530,345 | 1.1M | 1.8M | 1.1M |
| End Cash Position | 336,531 | 409,191 | 530,345 | 1.1M | 1.8M |
| Free Cash Flow | -72,660 | -121,154 | -598,263 | -647,302 | -269,941 |
| Income Tax Paid Supplemental Data | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Paid Supplemental Data | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Impairment Charge | 0.00 | 36,250 | -- | -- | 0.00 |
| Change In Prepaid Assets | 8,249 | 19,449 | 218,943 | -88,759 | -87,137 |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | 1.0M |
| Gain Loss On Investment Securities | -- | 10,000 | -- | -- | -- |
| Gain Loss On Sale Of PPE | 0.00 | -241,213 | -- | -- | 0.00 |
| Net Income From Continuing Operations | -102,497 | 112,008 | 312,314 | 150,858 | -303,905 |
| Net Other Financing Charges | -- | -- | 10,232 | 0.00 | -36,751 |
| Operating Gains Losses | 0.00 | -241,213 | -- | -- | -- |
| Unrealized Gain Loss On Investment Securities | 10,000 | 10,000 | -350,000 | -320,000 | 0.00 |